Blennow K - Search Results

1

Stable cerebrospinal fluid neurogranin and β-site amyloid precursor protein cleaving enzyme 1 levels differentiate predementia Alzheimer's disease patients.

Kirsebom BE, Richter G, Nordengen K, Aarsland D, Bråthen G, Tijms BM, Visser PJ, Nilsson J, Selnes P, Kramberger MG, Winblad B, Waterloo K, Gísladóttir B, Blennow K, Fladby T. Kirsebom BE, et al. Among authors: blennow k. Brain Commun. 2022 Sep 24;4(5):fcac244. doi: 10.1093/braincomms/fcac244. eCollection 2022. Brain Commun. 2022. PMID: 36262371 Free PMC article.

2

Cerebrospinal fluid tau protein as a biochemical marker for Alzheimer's disease: a community based follow up study.

Andreasen N, Vanmechelen E, Van de Voorde A, Davidsson P, Hesse C, Tarvonen S, Räihä I, Sourander L, Winblad B, Blennow K. Andreasen N, et al. Among authors: blennow k. J Neurol Neurosurg Psychiatry. 1998 Mar;64(3):298-305. doi: 10.1136/jnnp.64.3.298. J Neurol Neurosurg Psychiatry. 1998. PMID: 9527138 Free PMC article.

3

Prevalence and incidence of clinically diagnosed memory impairments in a geographically defined general population in Sweden. The Piteå Dementia Project.

Andreasen N, Blennow K, Sjödin C, Winblad B, Svärdsudd K. Andreasen N, et al. Among authors: blennow k. Neuroepidemiology. 1999;18(3):144-55. doi: 10.1159/000026206. Neuroepidemiology. 1999. PMID: 10202268

4

Cerebrospinal fluid beta-amyloid(1-42) in Alzheimer disease: differences between early- and late-onset Alzheimer disease and stability during the course of disease.

Andreasen N, Hesse C, Davidsson P, Minthon L, Wallin A, Winblad B, Vanderstichele H, Vanmechelen E, Blennow K. Andreasen N, et al. Among authors: blennow k. Arch Neurol. 1999 Jun;56(6):673-80. doi: 10.1001/archneur.56.6.673. Arch Neurol. 1999. PMID: 10369305

5

Cerebrospinal fluid tau and Abeta42 as predictors of development of Alzheimer's disease in patients with mild cognitive impairment.

Andreasen N, Minthon L, Vanmechelen E, Vanderstichele H, Davidsson P, Winblad B, Blennow K. Andreasen N, et al. Among authors: blennow k. Neurosci Lett. 1999 Sep 24;273(1):5-8. doi: 10.1016/s0304-3940(99)00617-5. Neurosci Lett. 1999. PMID: 10505638 Clinical Trial.

6

Growth-associated protein GAP-43 in the frontal cortex and in the hippocampus in Alzheimer's disease: an immunohistochemical and quantitative study.

Bogdanovic N, Davidsson P, Volkmann I, Winblad B, Blennow K. Bogdanovic N, et al. Among authors: blennow k. J Neural Transm (Vienna). 2000;107(4):463-78. doi: 10.1007/s007020070088. J Neural Transm (Vienna). 2000. PMID: 11215757

7

The new cholesterol controversy - a little bit of history repeating?

Kivipelto M, Solomon A, Blennow K, Olsson AG, Winblad B. Kivipelto M, et al. Among authors: blennow k. Acta Neurol Scand Suppl. 2006;185:1-2. doi: 10.1111/j.1600-0404.2006.00678.x. Acta Neurol Scand Suppl. 2006. PMID: 16866903 No abstract available.

8

Effect of phenserine treatment on brain functional activity and amyloid in Alzheimer's disease.

Kadir A, Andreasen N, Almkvist O, Wall A, Forsberg A, Engler H, Hagman G, Lärksäter M, Winblad B, Zetterberg H, Blennow K, Långström B, Nordberg A. Kadir A, et al. Among authors: blennow k. Ann Neurol. 2008 May;63(5):621-31. doi: 10.1002/ana.21345. Ann Neurol. 2008. PMID: 18300284 Clinical Trial.

9

Reduced cerebrospinal fluid BACE1 activity in multiple sclerosis.

Mattsson N, Axelsson M, Haghighi S, Malmeström C, Wu G, Anckarsäter R, Sankaranarayanan S, Andreasson U, Fredrikson S, Gundersen A, Johnsen L, Fladby T, Tarkowski A, Trysberg E, Wallin A, Anckarsäter H, Lycke J, Andersen O, Simon AJ, Blennow K, Zetterberg H. Mattsson N, et al. Among authors: blennow k. Mult Scler. 2009 Apr;15(4):448-54. doi: 10.1177/1352458508100031. Epub 2009 Jan 19. Mult Scler. 2009. PMID: 19153172

10

Prevalence and prognostic value of CSF markers of Alzheimer's disease pathology in patients with subjective cognitive impairment or mild cognitive impairment in the DESCRIPA study: a prospective cohort study.

Visser PJ, Verhey F, Knol DL, Scheltens P, Wahlund LO, Freund-Levi Y, Tsolaki M, Minthon L, Wallin AK, Hampel H, Bürger K, Pirttila T, Soininen H, Rikkert MO, Verbeek MM, Spiru L, Blennow K. Visser PJ, et al. Among authors: blennow k. Lancet Neurol. 2009 Jul;8(7):619-27. doi: 10.1016/S1474-4422(09)70139-5. Epub 2009 Jun 10. Lancet Neurol. 2009. PMID: 19523877

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

2,087 results

Search Page